Scott D. Gleason

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

Scott D. Gleason, Harlan E. Shannon · Psychopharmacology · 1997 · 217 citations

Molecular Pharmacology, Psychiatry, Medicine +6

Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism

Akihiko Kato, Kevin D. Burris, Kevin M. Gardinier et al. · Nature Medicine · 2016 · 88 citations · Full text

Synaptic Transmission, Neurotransmitter, Neuromodulation Therapies +18

Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models

Ruud Zwart, Emanuele Sher, Xingjie Ping et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 68 citations

Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8

Kevin M. Gardinier, Douglas L. Gernert, Warren J. Porter et al. · Journal of Medicinal Chemistry · 2016 · 58 citations · Full text

Motor Impairment, Synaptic Transmission, Neuromodulation Therapies +25

m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors

Scott D. Gleason, Virginia L. Lucaites, H.E. Shannon et al. · Behavioural Pharmacology · 2001 · 53 citations

5-Ht2c Receptors, Pharmacotherapy, Medicinal Chemistry +19